Avant Technologies and Ainnova Collaborate with Apollo Hospitals to Boost AI in Healthcare

Avant Technologies and Ainnova Tech have announced a strategic collaboration with Apollo Hospitals to integrate artificial intelligence into disease detection and prediction. With Ainnova's Vision AI platform, AI algorithms validated with over 2.3 million data points enable early detection of diseases like cardiovascular and chronic kidney diseases, liver fibrosis, diabetes, and lung conditions.

The partnership allows for the global development and marketing of Ainnova's technology, emphasizing expansion into the Americas and Brazil. This collaboration aligns with enhancing chronic disease management and aims to improve patient referrals to specialist care.

Apollo Hospitals, a significant healthcare network in Asia, reinforces its commitment to global healthcare innovation. By partnering with Ainnova, Apollo enhances its reach in the Americas and aims to introduce further AI-driven healthcare solutions in the future.